.jpg)
معرفی
Dr. Espen Molden is an Adjunct Professor at the Department of Pharmacy, University of Oslo, holding a 20% position while serving as Research Manager at the Center for Psychopharmacology, Diakonhjemmet Hospital. He earned his Cand.pharm. degree from the University of Oslo in 1997 and completed his Dr.scient. there in 2003. His primary research focuses on individual variability in drug efficacy and side effects, with particular emphasis on implementing pharmacogenetic knowledge in clinical practice.
His research interests span multiple areas of pharmacology, including:
- Pharmacokinetics and therapeutic drug monitoring
- Pharmacogenetics (particularly CYP2D6 and CYP2C19)
- Drug interactions and cytochrome P450 metabolism
- Clinical applications in psychopharmacology
Analysis of his 15 most recent publications (2024-2025) reveals a strong focus on pharmacogenetics applications in clinical settings, particularly in psychopharmacology. His work heavily features therapeutic drug monitoring studies, CYP enzyme polymorphisms, and their clinical implications for antipsychotic and antidepressant treatments. A significant portion of his recent work examines clozapine metabolism, CYP2D6-related pharmacogenetics, and real-world data applications in personalized medicine.
His scientific achievements include:
- Pharmacist of the Year award from the Norwegian Pharmaceutical Association (2006)
- Extensive publication record in high-impact journals including Nature Genetics, JAMA, and Clinical Pharmacology & Therapeutics
- Leadership in large collaborative research projects across multiple institutions
Dr. Molden actively collaborates with numerous researchers including Professor Torgeir Bruun Wyller at Oslo University Hospital, Professor Anette Hylen Ranhoff at Diakonhjemmet Hospital, and international colleagues from institutions like Karolinska Institutet. His work bridges basic pharmacogenetic research with clinical implementation, particularly in psychiatric medication management.
